The present invention relates to devices and methods which involve skin contact sensors for dermatologic treatment, and more particularly relates to capacitive sensors in dermatologic devices for detecting the proximity of human skin.
Many skin treatment devices require contact between an active area of the device and the skin for reasons of safety and/or efficacy.
For example, in light-based hair removal systems, the light energy is typically delivered through a transparent surface that makes contact with the skin. In such systems, the active area of the device is the light-emitting surface, and contact between this surface and the area of the skin to be treated is desirable both to ensure good transmission of the light to the treatment area, and, depending upon whether the device is otherwise eye safe, to aid in eye safety by eliminating stray light that might pose an eye hazard. At the same time, it is desirable to provide a system which does not require that the light-emitting surface be pressed into the skin to such a degree that the skin deforms.
Other examples of treatment devices that require skin contact include (1) devices that require contact only to prevent light leakage, such as a UV illuminator that requires no skin cooling but has a contacting baffle to prevent stray light, or (2) devices that require contact only for their mechanism of action and not to prevent light leakage, such as a thermal heater that delivers a pulse of heat through direct conduction to the skin. Other dermatological devices and methods that involve skin contact include ultrasound and radio frequency applications, such as wrinkle reduction. Some dermatological devices and methods provide skin contact through an interface material, such as ultrasound gel, oil, water, or index matching fluid. It is to be understood that these devices and methods are still considered to be skin contacting for the purposes of this application.
A significant problem for such devices is that the operator may angle or tilt the device's applicator such that it is not substantially perpendicular to the skin. This can create the situation where the entire surface of the active area is not in contact with the skin, and therefore the objective of efficacy and, for those devices which are not otherwise eye safe, will not be achieved.
Another problem for light-based devices is to ensure that the light-emitting surface is contacting a surface appropriate for treatment rather than, for example, eyeglasses. Typical contact sensors would generally sense positive contact if an applicator was applied to a person's eyeglasses, creating a potential for emission directly into the eye that, for many devices, could lead to serious injury or blindness. A similar condition could be created with household window panes or other similar transparent surfaces, whereby a contact sensor could sense contact against the window and light could be dangerously emitted into the ambient environment. It is desirable, therefore, for a dermatologic contact sensor not to be activated by eyeglasses or similar surfaces, but preferably only by a surface suitable for treatment.
A review of the state of the art shows that the existing devices and methods have important deficiencies. In particular, the existing designs do not solve the problem described above where the device applicator is applied at an angle and do not properly detect skin. While various mechanical systems exist which attempt to prevent dangerous emissions, most mechanical devices are complicated, costly and unreliable, as well as other shortcomings. A key advantage of capacitive sensing is its inherent imperviousness to ESD damage since no direct electrical connection to the skin is required. Although not necessary for capacitive sensing, it is possible to insulate the sensors of a capacitive sensor with a thin, electrically insulating, dielectric material.
Thus, there is a clear need for a practical contact sensor for skin treatment devices that would detect skin contact and also ensure skin contact across the entire active area of the device.
The foregoing and other problems and disadvantages of contact sensors in skin treatment devices are overcome by the present invention of a dermatologic treatment device comprising a capacitive skin sensing structure. The capacitive sensing structure permits activation of an associated treatment source only when skin is detected and the active area of the treatment source is properly in contact with the treatment area. In an embodiment, the capacitive sensing structure comprises a plurality of sensors, for example, three, positioned around the periphery of the treatment area. Each sensor is a planar metal region that forms one electrode of a parallel plate capacitor, the second electrode being formed by a corresponding region of the skin. By properly arranging the sensors around the active area, when the capacitive sensing structure contacts skin, the user can be assured that the active area of the treatment device is also in contact with skin, even though no deformation of the skin is necessary. The juxtaposition of skin against the sensing structure causes the capacitance of the sensing structure to change with an identifiable characteristic such that associated control circuitry can detect the difference. Once that change is capacitance is detected, the control circuitry permits the treatment source to be activated. At the same time, juxtaposition of other materials against the surface does not properly change the capacitance of the sensor, and the associated control circuitry will not permit the treatment source to be activated.
In one embodiment the treatment source includes a source of electromagnetic radiation, and the active area of the treatment source comprises a window through which electromagnetic radiation is emitted. The source of electromagnetic radiation and the dermatologic treatment can be configured to provide hair regrowth inhibition. In such an embodiment, activation of the source of magnetic radiation will be inhibited unless contact with skin is sensed by way of the sensors, without requiring deformation of the skin.
Other embodiments of the dermatologic treatment device are contemplated in which the treatment source is a source of electromagnetic radiation which is configured for such treatments as acne treatment, photorejuvenation, wrinkle reduction, depigmentation, or repigmentation, and the activation of the source of magnetic radiation is inhibited unless contact with skin is sensed by way of the capacitive sensing structure.
In further embodiments of the present invention, the active area of the treatment device is surrounded by a bezel which forms a substantially planar surface with the active area. The capacitive sensors are maintained behind the bezel but in sufficiently close proximity to it that they can sense the presence of skin. The substantially planar surface ensures good contact between the active area and the skin without deformation of the skin. In other embodiments, the active area can be placed forward of the bezel surface, and the sensitivity of the capacitive sensor structure can be configured to permit activation of the treatment source without deformation of the skin. In still other embodiments, the active area can be placed sufficiently forward of the skin sensing structure that deformation of the skin is required before the capacitive sensor will permit activation of the treatment source. In other embodiments, the number of skin contacting sensors is varied from one to six or more.
Other embodiments comprise a capacitive skin sensor that is activated when the active area is merely in close proximity to the skin, and can be used for procedures in which any contact with the skin is undesirable. In yet another embodiment of the present invention, the sensors are merely small conductive contact areas, for example on the order of one millimeter in diameter. Each of the sensors are electrically connected to an associated, remotely located fixed capacitor. In an embodiment, one capacitor is associated with each contact area, although this one-to-one correspondence is not necessarily used in every such embodiment.
In accordance with the present invention, a method for providing a skin contact sensor in a dermatologic treatment device having a skin contacting structure and a treatment source capable of being activated to supply a dermatologic treatment through the skin contacting structure, includes the steps of positioning a plurality of capacitive sensors around a periphery of the active area of a treatment source, and inhibiting activation of the treatment source unless the present of skin is indicated by signals from the plurality of sensors. The method can further include the step of configuring the active area together with the plurality of sensors so that no deformation of the skin is required, and can, alternatively, include the step of configuring the active area relative to the sensors so that deformation of the skin is required.
It is therefore an object of the present invention to provide a skin contact sensor and method suitable for use in dermatologic treatment devices.
It is another object of the present invention to provide a skin contact sensor and method for dermatologic treatment devices in which the skin contact sensor inhibits activation of a treatment source in the device unless contact with a compliant surface is sensed.
It is a further object of the present invention to provide a dermatologic treatment device having a skin contact sensor including a plurality of sensors positioned around a periphery of a skin contacting structure and circuitry coupled to the plurality of sensors and configured to inhibit activation of a treatment source in the device other than in the presence of skin.
It is still another object of the present invention to provide a skin contact sensor and method for use in dermatologic treatment devices in which a plurality of sensors are positioned around a treatment window and the plurality of sensors are positioned relative to a skin contacting surface such that no deformation of skin is required during use of the treatment device.
It is a still further object of the present invention to provide a skin contact sensor configuration and method in a dermatologic treatment device in which a three or more sensors are positioned around a treatment window and a skin-contacting surface of the treatment window is substantially coplanar with a bezel.
These and other objectives, advantages and features of the present invention will be more readily understood upon considering the following detailed description of certain preferred embodiments of the present invention, and the accompanying drawings.
Attention is drawn to the aforementioned Related Applications. It will be appreciated by those skilled in the art that aspects and features disclosed in those applications may be configured so as to be suitable for use with the contact sensor device and method described herein.
Referring first to
In the device of
In addition, and as shown particularly in
To prevent artifact signals from occurring, the ribbon cable 75, for some embodiments, comprises a polyimide base layer and polyimide coverlay of sufficient thickness to prevent contaminants from being deposited in close proximity to the inner conductive traces. In some embodiments, polyimide thickness in the range of one to ten or more one-thousandths of an inch can be used if necessary to provide a sufficient insulation layer to prevent the ribbon cable from providing sufficient stray capacitance to affect the operation of the sensors 70A-C.
From
Referring next to
For the treatment device shown in
In some embodiments, it is desirable to calibrate the sensors since the sensitivity of the sensors can vary somewhat from device to device. This calibration can be achieved during manufacturing as shown in
It will be appreciated by those skilled in the art that numerous alternatives and equivalents can be implemented without deviating from the invention. As some examples, various sensor geometries can be used, including varying the number of sensors, the effective size of the sensors, the distance the sensor is recessed from the active skin-contacting surface of the device, and other such configurations. In an embodiment of the present invention, such as that illustrated in the Figures, the active area of each sensor 70 is less on the order of 0.200″×0.150″ [dimensions].
Likewise, other types of sensor circuitry can be used. The sensor output can be processed purely in hardware, or the device can employ a variety of different software and/or hardware algorithms to change safety, reliability, or effectiveness characteristics, such as allowing use if three of four buttons indicated contact. Additionally, the circuitry can compare signals from the sensors for various additional purposes, such as to estimate the total heat flux through the contact surface.
It will therefore be appreciated that, while exemplary drawings and specific embodiments of the present invention have been described and illustrated, the scope of the present invention is not be limited to the particular embodiments discussed. The embodiments shown and described are to be regarded as illustrative rather than restrictive, and the invention is to be limited only by the appended claims.
In addition, in methods that may be performed according to preferred embodiments herein and that may have been described above, the operations have been described in selected sequences. However, the sequences have been selected and so ordered for solely for clarity and convenience and are not intended to imply a requirement for any particular order for performing the operations, unless expressly set forth in the claims or as understood by those skilled in the art as being necessary.
This application claims the benefit of U.S. 60/954,682 filed Aug. 8, 2007. This application is a continuation-in-part of (a) U.S. Ser. No. 10/783,607, filed Feb. 19, 2004, issued as U.S. Pat. No. 7,118,563, which claims the benefit of U.S. Provisional Application Nos. 60/450,243, filed Feb. 25, 2003; 60/450,598, filed Feb. 26, 2003; 60/451,091, filed Feb. 28, 2003; 60/452,304, filed Mar. 4, 2003; 60/451,981, filed Mar. 4, 2003; 60/452,591, filed Mar. 6, 2003; 60/456,379, filed Mar. 20, 2003; 60/456,586, filed Mar. 21, 2003; 60/458,861, filed Mar. 27, 2003; and 60/472,056, filed May 20, 2003; (b) U.S. Ser. No. 11/545,963, filed Oct. 10, 2006, which is a continuation of (a) U.S. Ser. No. 10/783,607; (c) U.S. Ser. No. 10/783,603, filed Feb. 19, 2004, issued as U.S. Pat. No. 7,452,356; (d) U.S. Ser. No. 10/783,880, filed Feb. 19, 2004, issued as U.S. Pat. No. 7,250,045, (e) U.S. Ser. No. 10/787,720, filed Feb. 25, 2004, issued as U.S. Pat. No. 7,413,567; (f) U.S. Ser. No. 10/787,969, filed Feb. 25, 2004, issued as U.S. Pat. No. 7,981,111; (g) U.S. Ser. No. 10/788,167, filed Feb. 25, 2004; (h) U.S. Ser. No. 11/829,747, filed Jul. 27, 2007, and (i) U.S. Ser. No. 10/794,504, filed Mar. 5, 2004, all of which applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3307533 | Meredith et al. | Mar 1967 | A |
3538919 | Meyer | Nov 1970 | A |
3622743 | Muncheryan | Nov 1971 | A |
3693623 | Harte et al. | Sep 1972 | A |
3821510 | Muncheryan | Jun 1974 | A |
3834391 | Block | Sep 1974 | A |
4232678 | Skovajsa | Nov 1980 | A |
4240738 | Praamsma | Dec 1980 | A |
4354092 | Manabe et al. | Oct 1982 | A |
4388924 | Weissman et al. | Jun 1983 | A |
4423736 | Dewitt et al. | Jan 1984 | A |
4551628 | Grossman | Nov 1985 | A |
4573466 | Simada et al. | Mar 1986 | A |
4592353 | Daikuzono | Jun 1986 | A |
4608978 | Rohr | Sep 1986 | A |
4617926 | Sutton | Oct 1986 | A |
4690141 | Castel et al. | Sep 1987 | A |
4733660 | Itzkan | Mar 1988 | A |
4829262 | Furumoto | May 1989 | A |
4846184 | Comment et al. | Jul 1989 | A |
4905690 | Ohshiro et al. | Mar 1990 | A |
4930504 | Diamantopoulos et al. | Jun 1990 | A |
5057104 | Chess | Oct 1991 | A |
5059013 | Jain | Oct 1991 | A |
5059192 | Zaias | Oct 1991 | A |
5075971 | Mccambridge | Dec 1991 | A |
5109465 | Klopotek | Apr 1992 | A |
5226907 | Tankovich | Jul 1993 | A |
5259380 | Mendes et al. | Nov 1993 | A |
5282797 | Chess | Feb 1994 | A |
5295052 | Chin et al. | Mar 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5360426 | Muller et al. | Nov 1994 | A |
5401270 | Muller et al. | Mar 1995 | A |
5405368 | Eckhouse | Apr 1995 | A |
5425728 | Tankovich | Jun 1995 | A |
5431647 | Purcell, Jr. et al. | Jul 1995 | A |
5464434 | Alt | Nov 1995 | A |
5464436 | Smith | Nov 1995 | A |
5473408 | Hoffman et al. | Dec 1995 | A |
5486172 | Chess | Jan 1996 | A |
5519534 | Smith et al. | May 1996 | A |
5549660 | Mendes et al. | Aug 1996 | A |
5556612 | Anderson et al. | Sep 1996 | A |
5595568 | Anderson et al. | Jan 1997 | A |
5606798 | Kelman | Mar 1997 | A |
5624435 | Furumoto et al. | Apr 1997 | A |
5628744 | Coleman et al. | May 1997 | A |
5630811 | Miller | May 1997 | A |
5632741 | Zavislan et al. | May 1997 | A |
5643252 | Waner et al. | Jul 1997 | A |
5647866 | Zaiase et al. | Jul 1997 | A |
5658323 | Miller | Aug 1997 | A |
5669916 | Anderson | Sep 1997 | A |
5683380 | Eckhouse et al. | Nov 1997 | A |
5700240 | Barwick, Jr. et al. | Dec 1997 | A |
5707403 | Grove et al. | Jan 1998 | A |
5728090 | Martin et al. | Mar 1998 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5743901 | Grove et al. | Apr 1998 | A |
5752948 | Tankovich et al. | May 1998 | A |
5752949 | Tankovich et al. | May 1998 | A |
5766214 | Mehl, Sr. et al. | Jun 1998 | A |
5769844 | Ghaffari | Jun 1998 | A |
5817089 | Tankovich et al. | Oct 1998 | A |
5820625 | Izawa et al. | Oct 1998 | A |
5824023 | Anderson | Oct 1998 | A |
5843072 | Furumoto et al. | Dec 1998 | A |
5846252 | Mehl, Sr. | Dec 1998 | A |
5849029 | Eckhouse et al. | Dec 1998 | A |
5853407 | Miller | Dec 1998 | A |
5868732 | Waldman et al. | Feb 1999 | A |
5871479 | Furumoto et al. | Feb 1999 | A |
5871480 | Tankovich | Feb 1999 | A |
5871521 | Kaneda et al. | Feb 1999 | A |
5879346 | Waldman et al. | Mar 1999 | A |
5885273 | Eckhouse et al. | Mar 1999 | A |
5966210 | Rosow et al. | Oct 1999 | A |
5968034 | Fullmer et al. | Oct 1999 | A |
5989267 | Anderson | Nov 1999 | A |
6015404 | Altshuler et al. | Jan 2000 | A |
RE36634 | Ghaffari | Mar 2000 | E |
6059765 | Cole et al. | May 2000 | A |
6080146 | Altshuler et al. | Jun 2000 | A |
6096029 | O'Donnell, Jr. | Aug 2000 | A |
6106514 | O'Donnell, Jr. | Aug 2000 | A |
6114862 | Tartagni et al. | Sep 2000 | A |
6138041 | Yahia | Oct 2000 | A |
6160831 | Kleinschmidt et al. | Dec 2000 | A |
6183500 | Kohler | Feb 2001 | B1 |
6183773 | Anderson | Feb 2001 | B1 |
6188495 | Inoue et al. | Feb 2001 | B1 |
6197020 | O'donnell, Jr. | Mar 2001 | B1 |
6208749 | Gutkowicz-krusin et al. | Mar 2001 | B1 |
6228074 | Almeida | May 2001 | B1 |
6251127 | Biel | Jun 2001 | B1 |
6269818 | Lui et al. | Aug 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6273885 | Koop et al. | Aug 2001 | B1 |
6277111 | Clement et al. | Aug 2001 | B1 |
6280438 | Eckhouse et al. | Aug 2001 | B1 |
6290713 | Russell | Sep 2001 | B1 |
6322584 | Ingle et al. | Nov 2001 | B2 |
6379376 | Lubart | Apr 2002 | B1 |
6436127 | Anderson et al. | Aug 2002 | B1 |
6440122 | Shimoji | Aug 2002 | B1 |
6441943 | Roberts et al. | Aug 2002 | B1 |
6485484 | Connors et al. | Nov 2002 | B1 |
6494900 | Salansky et al. | Dec 2002 | B1 |
6508813 | Alshuler | Jan 2003 | B1 |
6511475 | Altshuler et al. | Jan 2003 | B1 |
6514242 | Vasily et al. | Feb 2003 | B1 |
6516013 | Patzel et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6533775 | Rizoiu | Mar 2003 | B1 |
6536914 | Hoelen et al. | Mar 2003 | B2 |
6548781 | Brunwinkel | Apr 2003 | B1 |
6563853 | Heist et al. | May 2003 | B2 |
6600951 | Anderson | Jul 2003 | B1 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6610052 | Furumoto | Aug 2003 | B2 |
6621702 | Elias et al. | Sep 2003 | B2 |
6641044 | Plesko | Nov 2003 | B2 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
6653618 | Zenzie | Nov 2003 | B2 |
6659999 | Anderson et al. | Dec 2003 | B1 |
6660000 | Neuberger et al. | Dec 2003 | B2 |
6663620 | Altshuler et al. | Dec 2003 | B2 |
6663659 | Mcdaniel | Dec 2003 | B2 |
6666856 | Connors et al. | Dec 2003 | B2 |
6723090 | Altshuler et al. | Apr 2004 | B2 |
6887260 | Mcdaniel | May 2005 | B1 |
6902563 | Wilkens et al. | Jun 2005 | B2 |
7068910 | Duine et al. | Jun 2006 | B2 |
7452356 | Grove et al. | Nov 2008 | B2 |
20010023363 | Harth et al. | Sep 2001 | A1 |
20010046131 | Hoelen et al. | Nov 2001 | A1 |
20020005475 | Zenzie | Jan 2002 | A1 |
20020015430 | Osmanow et al. | Feb 2002 | A1 |
20020031160 | Desor | Mar 2002 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020091377 | Anderson et al. | Jul 2002 | A1 |
20020097587 | Krietzman et al. | Jul 2002 | A1 |
20020128635 | Altshuler et al. | Sep 2002 | A1 |
20020128695 | Harth et al. | Sep 2002 | A1 |
20020151887 | Stern et al. | Oct 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020161418 | Wilkens et al. | Oct 2002 | A1 |
20020173780 | Altshuler et al. | Nov 2002 | A1 |
20020173833 | Korman et al. | Nov 2002 | A1 |
20020183811 | Irwin | Dec 2002 | A1 |
20030004499 | Mcdaniel | Jan 2003 | A1 |
20030009158 | Perricone | Jan 2003 | A1 |
20030032950 | Altshuler et al. | Feb 2003 | A1 |
20030036751 | Anderson et al. | Feb 2003 | A1 |
20030046825 | Slingo | Mar 2003 | A1 |
20030050561 | Bazin et al. | Mar 2003 | A1 |
20030055413 | Altshuler et al. | Mar 2003 | A1 |
20030055414 | Altshuler et al. | Mar 2003 | A1 |
20030065314 | Altshuler et al. | Apr 2003 | A1 |
20030080755 | Kobayashi | May 2003 | A1 |
20030094714 | Buazza et al. | May 2003 | A1 |
20030105069 | Robinson et al. | Jun 2003 | A1 |
20030133292 | Mueller et al. | Jul 2003 | A1 |
20030138249 | Merola et al. | Jul 2003 | A1 |
20030146122 | Westfield et al. | Aug 2003 | A1 |
20030169400 | Buazza et al. | Sep 2003 | A1 |
20030177657 | Andis et al. | Sep 2003 | A1 |
20030195494 | Altshuler et al. | Oct 2003 | A1 |
20030199859 | Altshuler et al. | Oct 2003 | A1 |
20030216795 | Harth et al. | Nov 2003 | A1 |
20030220633 | Angeley et al. | Nov 2003 | A1 |
20030233138 | Spooner | Dec 2003 | A1 |
20040006328 | Anderson | Jan 2004 | A1 |
20040010298 | Altshuler et al. | Jan 2004 | A1 |
20040010299 | Tolkoff et al. | Jan 2004 | A1 |
20040034319 | Anderson et al. | Feb 2004 | A1 |
20040034341 | Altshuler et al. | Feb 2004 | A1 |
20040036975 | Slatkine | Feb 2004 | A1 |
20040073079 | Altshuler et al. | Apr 2004 | A1 |
20040093042 | Altshuler et al. | May 2004 | A1 |
20040116913 | Pilcher et al. | Jun 2004 | A1 |
20040120151 | Ostler et al. | Jun 2004 | A1 |
20040122492 | Harth et al. | Jun 2004 | A1 |
20040167499 | Grove et al. | Aug 2004 | A1 |
20040167500 | Weckwerth et al. | Aug 2004 | A1 |
20040167501 | Island et al. | Aug 2004 | A1 |
20040167502 | Weckwerth et al. | Aug 2004 | A1 |
20040167592 | Grove et al. | Aug 2004 | A1 |
20040176754 | Island et al. | Sep 2004 | A1 |
20040176823 | Island et al. | Sep 2004 | A1 |
20040225339 | Yaroslavsky et al. | Nov 2004 | A1 |
20050085878 | Wilkens et al. | Apr 2005 | A1 |
20050276072 | Hayashi et al. | Dec 2005 | A1 |
20060206103 | Altshuler et al. | Sep 2006 | A1 |
20070025947 | Hansenne et al. | Feb 2007 | A1 |
20070129711 | Altshuler et al. | Jun 2007 | A1 |
20070292461 | Tamarkin et al. | Dec 2007 | A1 |
20080125834 | Hendrix et al. | May 2008 | A1 |
20080147053 | Kang et al. | Jun 2008 | A1 |
Number | Date | Country |
---|---|---|
2442726 | Aug 2001 | CN |
19629978 | Jan 1998 | DE |
10044662 | Mar 2002 | DE |
10360503 | Jul 2005 | DE |
0761257 | Mar 1997 | EP |
0933096 | Aug 1999 | EP |
1116476 | Jul 2001 | EP |
1168535 | Jan 2002 | EP |
1358872 | Nov 2003 | EP |
2665366 | Feb 1992 | FR |
2932679 | Dec 2009 | FR |
11244295 | Sep 1999 | JP |
2000300683 | Oct 2000 | JP |
2001252363 | Sep 2001 | JP |
2004527330 | Sep 2004 | JP |
2006518614 | Aug 2006 | JP |
2006525036 | Nov 2006 | JP |
9614083 | May 1996 | WO |
0002491 | Jan 2000 | WO |
02094116 | Nov 2002 | WO |
03017824 | Mar 2003 | WO |
03049633 | Jun 2003 | WO |
2004075731 | Sep 2004 | WO |
2004080279 | Sep 2004 | WO |
2005063193 | Jul 2005 | WO |
2009089177 | Jul 2009 | WO |
Entry |
---|
European Search Report, Application No. 08797565.2, 6 pages, Oct. 29, 2012. |
Brunsting, L, et al., “The Color of the Skin as Analyzed by Spectrophotometric Methods, II. The Role of Pigmentation”, Section on Dermatology and Syphilology and the Division of Physics and Biophysical Research, The Mayo Foundation; pp. 575-592, Apr. 29, 1929. |
Brunsting, L, et al., The Color of the Skin as Analyzed by Spectrophotometric Methods, III. The Role of Superficial Blook, Section on Dermatology and Syphilology and the Division of Physics and Biophysical Research, The Mayo Foundation; pp. 593-613, Apr. 29, 1929. |
Miller, Steve et al., “Isolation and Characterization of Protoporphyrin IX from Bacterial Catalase,” The Journal of Biological Chemistry, vol. 235, No. 11, 3 pages, Mar. 7, 1960. |
Brown, E.B., “Modern Optics,” Radiometry and Photometry, Reinhold Publishing Corporation, 3 pages, 1965. |
Cornelius, C.E. et al., “Red Fluorescence of Comedones: Production of Porphyrins by Corynebacterium acnes,” The Journal of Investigative Dermatology, vol. 49(4), PMID: 4228644, [PubMed—Indexed for Medline], 3 pages, Oct. 1967. |
Dalton, J. et al., “Reaction Between Molecular Oxygen and Photo-excited Protoporphyrin IX,” Nature, vol. 235, 1 page, Feb. 18, 1972. |
Hoeffler, Ulrich, “Enzymatic and Hemolytic Properties of Propionibacterium acnes and Related Bacteria,” Journal of Clinical Microbiology, vol. 6, No. 6, 4 pages, Jun. 10, 1977. |
Formanek, I. et al., “Porphyrinsynthesis by Propionibacterium acnes (author's translation),” Archives for Dermatological Research, vol. 259(2), German, PMID: 334087 [PubMed—indexed for Medline], 9 pages, Aug. 22, 1977. |
Lee, W.L. et al., “Comparative Studies of Porphyrin Production in Propionibacterium acnes and Propionibaceterium granulosum,” Journal of Bacteriology, vol. 133(2), PMID: 637914 [PubMed—Indexed for Medline] 5 pages, Aug. 25, 1977. |
Mills, O.H. et al., “Ultraviolet Phototherapy and Photochemotherapy of Acne vulgaris,” Archives of Dermatological Research, , vol. 114(2), PMID: 147054 [PubMed: Indexed for Medline] 3 pages, Feb. 1978. |
Fanta, D. et al., “Porphyrinsynthesis of Propionibacterium acnes in Acne and Seborrhea (author's translation),” Archives of Dermatological Research, vol. 261, German, PMID: 148872 [PubMed—indexed for Medline], 5 pages, Apr. 7, 1978. |
McGinley, K.J. et al., “Facial Follicular Porphyrin Fluorescence: Correlation with Age and Density of Propionibacterium acnes,” British Journal of Dermatology, Vo. 102(4), PMID: 7387886 [PubMed—Indexed for Medline] 5 pages, Jul. 24, 1979. |
Sliney, D. et al., “Safety with Lasers and Other Optical Sources, A Comprehensive Handbook,” Plenum Press, 9 pages, Jul. 1980. |
Fanta, D. et al., “Porphyrin Synthesis by Propionibacteria in Dependence of External Factors,” Archives of Dermatological Research, vol. 271, 7 pages, Jul. 10, 1980. |
Melo, T.B. et al., “In Vivo Porphyrin Fluorescence for Propionibacterium acnes. A Characterization fo the Fluorescing Pigments,” Dermatologica, vol. 164(3), PMID: 7084539 [PubMed—Indexed for Medline] 9 pages, Mar. 1982. |
Parrish, J. et al., “Erythema and Melanogenesis Action Spectra of Normal Human Skin,” Photochemistry and Photobiology, vol. 36, 5 pages, Mar. 15, 1982. |
Kjeldstad, B. et al., “Influence of pH on Porphyrin Production in Propionibacterium acnes,” Archives of Dermatological Research, vol. 276(6), PMID: 6517611 [PubMed—Indexed for Medline] 5 pages, 1984. |
Melo, T.B. et al., “Photodestruction of Propionibacterium acnes Porphyrins,” Z. Naturforsch, vol. 40(C), PMID: 3993179 [PubMed—Indexed for Medline] 4 pages, Oct. 22, 1984. |
Kjeldstad, B. et al., “Porphyrin Photosensitization of Bacteria,” Adv. Exp. Med. Biol., PMID: 4096295 [PubMed—indexed for Medline], 5 pages, 1985. |
Kjeldstad, B. et al., “An Action Spectrum for Blue and Near Ultraviolet Inactivation of Propionibacterium acnes; with Emphasis on a Possible Porphyrin Photosensitization,” Photochemistry and Photobiology, vol. 43(1), PMID: 3952162 [PubMed—Indexed for Medline] 4 pages, Jul. 19, 1985. |
Guideline for Limits of Exposure to Ultraviolet Radiation of Wavelengths between 180 nm and 400 nm, Health Physics, vol. 49, No. 2, 10 pages, Aug. 1985. |
Meffert, H. et al., “Phototherapy of Acne vulgaris with the “TuR” UV 10 Body Section Irradiation Unit [translation],” Dermatol. Monatsscher., vol. 172, German, PMID: 2938991 [PubMed—Indexed for Medline] 6 pages, 1986. |
Meffert, H. et al., “Phototherapy of Acne vulgaris with the UVA Irradiation Instrument TBG 400 [translation],” Dermatol. Monatsscher, vol. 172, German, PMID: 2937663 [PubMed—Indexed for Medline] 2 pages, 1986. |
Johnsson, A. et al., “Fluorescence from Pilosebaceous Follicles,” Archives of Dermatological Research, vol. 279(3), PMID: 3592747 [PubMed—Indexed for Medline] 4 pages, 1987. |
Meffert, H. et al., “Treatment of Acne vulgaris with Visible Light [translation],” Dermatol. Monatsscher, vol. 173, German, PMID: 2963772 [PubMed—Indexed for Medline] 2 pages, 1987. |
Meffert, H. et al., “Verkuzung der Bestrahlungszeit Verwendung eines Hochruckstrahlers vom Blaulichttyp,” Dermatol. Mon. schr 176, 8 pages, 1990. |
Meffert, H. et al., “Therapy of Acne with Visible Light. Decreased Irradiation Time by Using a Blue-Light High-Energy Lamp [translation]” Dermatol. Monatsschr., German, PMID: 2150382 [PubMed—Indexed for Medline] 7 pages, 1990. |
Kjeldstad, B. et al., “Near-UV-Induced Radicals in Propionibacterium acnes, Studied by Electron Spin Resonance Spectrometry at 77 K.,” Journal of Photochemistry and Photobiology, vol. 9(2), PMID: 1650821 [PubMed—Indexed for Medline] 7 pages, Sep. 21, 1990. |
Morys et al., “The Accurate Measurements of Biologically Effective Ultraviolet Radiation,” International Symposium on High Latitude Optics, 10 pages, Jul. 1993. |
Webster, G.F., “Inflammation in Acne vulgaris,” Journal of the American Academy of Dermatology, vol. 33(2 Pt. 1), Review, PMID: 7622652 [PubMed—Indexed for Medline] 7 pages, Aug. 1995. |
Leung, S., “The Porphyrin Page,” website at http://www.washburn.edu-cas-chemistry-sleung-porphyrin/page.html, Created Apr. 16, 1996, Last Modified Nov. 11, 2002, printed Jun. 22, 2004, 7 pages, Apr. 16, 1996. |
Arakane, K. et al., “Singlet Oxygen (1 delta g) Generation from Coproporphyrin in Propionibacterium acnes on Irradiation,” Biochemical and Biophysical Research Communication, vol. 223, Article No. 0937, PMID: 8687438 [PubMed—Indexed for Medline], 6 pages, Jun. 25, 1996. |
Sigurdsson, V. et al., “Phototherapy of Acne vulgaris with Visible Light,” Dermatology, vol. 194(3), PMID: 9187844 [PubMed—Indexed for Medline] 5 pages, Nov. 15, 1996. |
Predicate Devices: LightSheer Diode Laser System by Star Medical/Coherent Star, K973324, K982940, K001746, 1997. |
Leyden, J., “Therapy for Acne vulgaris,” The New England Journal of Medicine, vol. 336, No. 16, Massachussetts Medical Society, 7 pages, Apr. 17, 1997. |
Leydon, J., “Therapy for Acne vulgaris,” The New England Journal of Medicine, Review Article, 6 pages, Apr. 17, 1997. |
UV Index definition, Canadian Environmental Web page, See entire document, 3 pages, Jun. 1, 1998. |
Karu, Tiina, “Primary and Secondary Mechanisms of Action of Visible to Near-IR Radiation on Cells,” Journal of Photochemistry and Photobiology, vol. 49, 17 pages, Nov. 9, 1998. |
Saiki, Hiroyasu et al., “Diffusion of Porphyrins and Quinones in Organic Solvents,” Phys. Chem. Chem Phys., vol. 1, 4 pages, 1999. |
Code of Federal Regulations, Class I Accessible Emmission Limits for Laser Radiation, Food and Drug Administration, HHS, 2 pages, Apr. 1, 1999. |
Yoo, Yeong-Min et al., “Hemoglobin Toxicity in Experimental Bacterial Peritonitis Is Due to Production of Reactive Oxygen Species,” Clinical and Diagnostic Laboratory Immunology, vol. 6, No. 6, 2 pages, Jul. 12, 1999. |
IEC Technical Report 60825-8, “Safety of Laser Products—Guide for the Safe Use of Medical Laser Equipment,” 6 pages, Nov. 1999. |
Papagcorgiou, P. et al., “Phototherapy wit Blue (415 nm) and Red (660 nm) Light in the Treatment of Acne vulgaris,” British Journal of Dermatology, vol. 142(5), PMID: 10809858 [PubMed—indexed for Medline] 6 pages, Dec. 7, 1999. |
Angelopoulou, E., “The Reflectance Spectrum of Human Skin”, Dept. of Computer & Information Science, Technical Reports (CIS), University of Pennsylvania; 14 pages, Dec. 20, 1999. |
Romiti, R. et al., “High-Performance Liquid Chromatography Analysis of Porphyrins in Propionibacterium acnes,” Archives of Dermatological Research, vol. 292(6), PMID: 10929774 [PubMed—Indexed for Medline] 3 pages, Jan. 7, 2000. |
Bagdonas, Saulius et al., “Phototransformations of 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Vitro: A Spectroscopic Study,” Photochemistry and Photobiology, vol. 72(2), 7 pages, May 6, 2000. |
Shalita, A. et al., “Acne Photoclearing (APC) Using a Novel, High-Intensity, Enhanced, Narrow-Band, Blue Light Source,” Clinical Application Notes, vol. 9(1), ESC Medical Systems Ltd., PB 558-0230, Rev. A, 4 pages, 2001. |
International Standard IEC 60825.1, Safety of Laser Products—Part 1: Equipment Classification, Requirements and User's Guide, Editon 1.2, 121 pages, 2001. |
Koval'skaya, N.E. et al., “The Efficiency of the Formation of Singlet. Oxygen by a Sensitizer Based on Zinc Phthlocyanine,” Journal of Applied Spectroscopy, vol. 68, No. 2, 4 pages, 2001. |
Buchezyk, Darius P. et al., “High Efficiency of 5-Aminolevulinate-Photodynamic Treatment Using UVA Irradiation,” Carcinogenesis, vol. 22, No. 6, 5 pages, 2001. |
Mason, Maria G. et al., “Extracellular Heme Peroxidases in Actinomycetes: a Case of Mistaken Identity,” Applied and Environmental Microbiology, vol. 67, No. 10, 8 pages, Jul. 18, 2001. |
Jappe, U. et al., “Propionibacterium acnes and Inflammation in Acne; P. acnes has T-Cell Mitogenic Activity,” British Journal of Dermatology, vol. 146, 8 pages, Sep. 12, 2001. |
Kawada, A. et al., “Acne Phototherapy with a High-Intensity, Enhanced, Narrow-Band, Blue Light Source: An Open Study and In Vitro Investigation,” Journal of Dermatological Science, vol. 30(2), PMID: 12413768 [PubMed—indexed for Medline] 7 pages, Jun. 19, 2002. |
Ashkenazi, H. et al., “Eradication of Propionibacterium acnes by its Endogenic Porphyrins after Illumination with High Intensity Blue Light,” FEMS Immunology and Medical Microbiology, vol. 35(1), PMID: 12589953 [PubMed: Indexed for MedLine], 8 pages, Jul. 24, 2002. |
Harnessing Light to Treat Stretch Marks and Other Hypopigmented Scars, Skin & Aging, Supplement to Nov. 2002 Skin & Aging. |
Elman et al., “The Effective Treatment of Acne vulgaris by a High-Intensity, Narrow Band 405-420 nm Light Source,” Journal of Cosmetic & Laser Therapy, vol. 5, 6 pages, Nov. 27, 2002. |
Hode, L., “Are Lasers More Dangerous than IPL Instruments?,” Lasers in Surgery and Medicine, Supplement 15, 3 pages, 2003. |
Wagener, Frank et al., “Different Faces of the Heme-Heme Oxygenase System in Inflammation,” Pharmaceutical Reviews, vol. 55, No. 3, The American Society for Pharmacology and Experimental Therapeutics, 21 pages, 2003. |
Anonymous, “Akne-Guidelines Schweiz,” [Online], Martin Pletscher: Dermatologie, Retrieved from Internet: http://www.martinpletscher.ch/dermatologie/akne.html, 5 pages, May 15, 2003. |
Burkhart, Craig N. et al., “Assessment of Etiologic Agents in Acne Pathogenesis,” Review, Department of Microbiology and Immunology, and Dermatology, Medical College of Ohio at Toledo, 7 pages, Jul. 2003. |
Micro Touch Trimmer website, www.asseenontvwork.com/vcc/ideavillage/microtouch/104917, printed Dec. 4, 2003, 21 pages. |
Charakida, A. et al., “Phototherapy in the Treatment of Acne vulgaris,” American Journal of Clinical Dermatology, vol. 5(4), Adis. Data Information, 6 pages, 2004. |
Elman, M. et al., “Light Therapy in the Treatment of Acne vulgaris,” Dermatological Surgery, vol. 30(2), Dermatology and Lasers Clinic, Tel Aviv and Caesarea, Israel, American Society for Dermatology Surgery, 8 pages, Feb. 2004. |
U.S. Appl. No. 10/794,676, by Mark V. Weckworth et al. entitled “Method and Apparatus for the Repigmentation of Human Skin”, Mar. 3, 2004. |
Elman, M. et al., “The Role of Pulsed Light and Hear Energy (LHE) in Acne Clearance,” Journal of Cosmetic Laser Therapy, vol. 6, 5 pages, Apr. 1, 2004. |
Omi, Tokuya et al., “420 nm Intense Continuous Light Therapy for Acne,” Journal of Cosmetic Laser Therapy, vol. 6, 7 pages, Aug. 12, 2004. |
Krautheim, A. et al., “Acne: Topical Treatment,” Clinics in Dermatology, vol. 22, No. 5, XP004647111, 10 pages, Sep. 1, 2004. |
Ross, Victor E., “Optical Treatment for Acne,” Deli iatologic Therapy, vol. 18, ISSN 1396-0296, 14 pages, 2005. |
Ross, Victor E., “Acne, Lasers, and Light,” Advances in Dermatology, vol. 21, 29 pages, 2005. |
Ortiz, Arisa et al., “A Review of Lasers and Light. Sources in the Treatment of Acne vulgaris,” Journal of Cosmetic and Laser Therapy, vol. 7, 7 pages, Mar. 7, 2005. |
Hamblin, M. et al., “Helicobacter phylori Accumulates Photoactive Porphyrins and Is Killed by Visible Light,” Antimicrobial Agents and Chemotherapy, vol. 49, No. 7, American Society for Microbiology, 6 pages, Mar. 7, 2005. |
Mariwalla, Kavita et al., “Use of Lasers and Light-Based Therapies for Treatment of Acne vulgaris,” Lasers in Surgery and Medicine, vol. 37, 10 pages, Oct. 12, 2005. |
Mariwalla, Kavita et al., “Non-Traditional Acne Therapy: The Use of Lasers and Light-Based Therapies,” US Dermatology Review 2006, 4 pages, 2006. |
Tremblay, J.F. et al., “Light-Emitting Diode 415 nm in the Treatment of Inflammatory Acne: An Open-Label, Multicentric, Pilot Investigation,” Journal of Cosmetic and Laser Therapy, vol. 8, 3 pages, Jan. 25, 2006. |
Goldberg, David J. et al., “Combination Blue (415 nm) and red (633 nm) LED Phototherapy in the Treatment of Mild to Severe Acne vulgaris,” Jornal of Cosmetic and Laser Therapy, vol. 8, 5 pages, Mar. 29, 2006. |
Lee, Seung Yoon et al., “Blue and Red Light Combination LED Phototherapy for Acne vulgaris in Patients with Skin Phototype IV,” Lasers in Surgery and Medicine, vol. 39, 9 pages, Nov. 16, 2006. |
Nestor, M., “The Use of Photodynamic Therapy for Treatment of Acne vulgaris,” Dermatologic Clinics, vol. 25, 11 pages, 2007. |
“Light Dose Ranging Study of Photodynamic Therapy (PDT) with Levulan + Blue Light in Severe Facial Acne,” DUSA Pharmaceuticals, Inc., http://clinicaltrials.gov/ct2/show/NCT00706433, 25 pages, Mar. 2007. |
Anonymous, “BlueLight Acne Treatments,” [Online], Retrieved from Internet: http://www.topdocs.com/display—procedure.php?id—bluelight, 2 pages, Apr. 10, 2008. |
“Comparison of Claro to Other Dermatological Devices for Acne Treatment,” Quantitative Assessment of Light Illumination on Organism Reduction; Subculture agar: TSA + 5% Sheep's Blood (Blood agar) Organism Diluent: Butterfield's Buffer or 0.85% Saline; Propionibacterium Acnes (ATCC 11827), 16 pages, Jun. 23, 2008. |
Anonymous, “Vi Derm Product Line,” [Online], Kalil Medical Products, Retrieved from Internet: http://www.kalilmedical.com/doctor/vi—derm—products.asp, 4 pages, Mar. 2, 2010. |
International Search Report, Application No. PCT/US2009/056961, 7 pages, Jun. 29, 2010. |
International Preliminary Report on Patentability, PCT/US2009/056961, 11 pages, Mar. 22, 2011. |
International Preliminary Report on Patentability, PCT/US2009/057204, 8 pages, Mar. 22, 2011. |
Supplementary European Search Report, Application No. 09815144, 9 pages, Feb. 10, 2012. |
European Office Action, Application No. 09815144.2, 6 pages, Oct. 10, 2012. |
Japanese Office Action, Application No. 2010-520342, 6 pages, Mar. 7, 2013. |
European Office Action, Application No. 09815144.2, 5 pages, Apr. 3, 2013. |
Japanese Final Office Action, Application No. 2010-520342, 6 pages, Aug. 20, 2013. |
Number | Date | Country | |
---|---|---|---|
20090043294 A1 | Feb 2009 | US |
Number | Date | Country | |
---|---|---|---|
60954682 | Aug 2007 | US | |
60450243 | Feb 2003 | US | |
60450598 | Feb 2003 | US | |
60451091 | Feb 2003 | US | |
60452304 | Mar 2003 | US | |
60451981 | Mar 2003 | US | |
60452591 | Mar 2003 | US | |
60456379 | Mar 2003 | US | |
60456586 | Mar 2003 | US | |
60458861 | Mar 2003 | US | |
60472056 | May 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10783607 | Feb 2004 | US |
Child | 11545963 | US | |
Parent | 12189079 | US | |
Child | 11545963 | US | |
Parent | 10783603 | Feb 2004 | US |
Child | 12189079 | US | |
Parent | 10783880 | Feb 2004 | US |
Child | 10783603 | US | |
Parent | 10787720 | Feb 2004 | US |
Child | 10783880 | US | |
Parent | 10787969 | Feb 2004 | US |
Child | 10787720 | US | |
Parent | 10788167 | Feb 2004 | US |
Child | 10787969 | US | |
Parent | 11829747 | Jul 2007 | US |
Child | 10788167 | US | |
Parent | 10794504 | Mar 2004 | US |
Child | 11829747 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10783607 | Feb 2004 | US |
Child | 12189079 | US | |
Parent | 11545963 | Oct 2006 | US |
Child | 10783607 | US |